MedTrace Logo

Warfarin Patient Self-management Implementation in the US Healthcare System

NCT04766216 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-05-08

No results posted yet for this study

Summary

In the US, patients receiving warfarin therapy are rarely allowed to engage in patient self-management (PSM) which is less burdensome, less expensive, and safer than standard clinic-directed warfarin management. The long-term objective of our application is to improve the safety of ambulatory warfarin therapy through increasing the implementation of PSM.

Conditions

Interventions

OTHER

Patient self-management

Patient makes independent decisions regarding warfarin therapy changes using warfarin dosing tools

OTHER

Usual care provided by anticoagulation providers

Normal care provided by anticoagulation providers

Sponsors & Collaborators

  • Brigham and Women's Hospital

    collaborator OTHER

  • University of Michigan

    collaborator OTHER

  • VA Loma Linda Health Care System

    collaborator FED

  • Kaiser Foundation Research Institute

    collaborator OTHER

  • University of Utah

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2024-05-31
Completion
2025-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766216 on ClinicalTrials.gov